January 19, 2012 — Multisite cryoablation of metastatic epithelial ovarian cancer is well tolerated, has a 5-year overall survival rate of 30%, and is cost effective, compared with other forms of ...

Six-year outcomes from the FROST trial show breast cancer cryoablation achieved low ipsilateral recurrence and high invasive ...

While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...

Please provide your email address to receive an email when new articles are posted on . Cryoablation may be an effective primary treatment option for women with low-risk breast cancer, according to ...

IceCure Medical Ltd ICCM recently announced that it has received marketing authorization from the FDA for its next-generation single probe cryoablation system, XSense Cryoablation System with ...

In contrast to radiation and surgery, a relatively new procedure could help “melt” breast cancer, and take less time. “The first thing that happens is the needle goes right through the cancer,” Dr.

The global ablation technology market growth is driven by rising cardiovascular and cancer cases, and the increasing adoption ...

Steve Biko Academic Hospital in Pretoria has made history by performing South Africa's first cryoablation procedure, marking a significant advancement in public healthcare and access to innovative ...

7-partial-nephrectomy-0516 Among patients with pT1b renal cell carcinoma, cryoablation is associated with a 2.5-fold higher 5-year cancer-specific mortality rate compared with partial nephrectomy, a ...

Cryoablation is a fairly new treatment being used to treat small cancer tumors. Could we soon see it offered as an alternative to traditional breast cancer surgeries? There isn’t a day that goes by ...